Participation of Mucosal Type I Interferon Signaling in Pulmonary Disease

粘膜 I 型干扰素信号转导参与肺部疾病

基本信息

  • 批准号:
    7862608
  • 负责人:
  • 金额:
    $ 19.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Participation of mucosal type I interferon signaling in pulmonary host defenses mucosal epithelial cells provide both barrier and signaling functions to initiate innate immune responses to bacterial infection in the respiratory tract. Particularly in the airways, the regulation of this initial proinflammatory signaling is critical. In addition to activating NF-?B-dependent proinflammatory genes in response to pathogens, airway mucosal cells also produce type I interferons, IFNs a and ¿ which result in Jak-Stat signaling and the activation of >300 effectors of the IFN-¿ cascade. This cascade is best known for its major role in protection from viral infection, but is likely to have important effects on host defense against bacterial infection as well. In this project we will characterize how common mucosal pathogens, S. pneumoniae, S. aureus and P. aeruginosa activate type I IFN signaling; by identifying the receptors and signaling components that are activated in mucosal epithelial cells and by characterizing how these effectors affect susceptibility to infection. IFN-¿ expression is significantly increased in the airways in response to influenza infection. The local consequences of upregulated IFN-¿ signaling are postulated to enhance susceptibility to secondary bacterial infection, the major cause of influenza- associated mortality. This will be tested in a murine model of influenza, using influenza mutants with differing abilities to stimulate IFN-¿ production and comparing how they affect susceptibility to bacterial superinfection. We predict that mucosal epithelial IFN-¿ production, possibly through effects in activating pulmonary dendritic cells, increases host susceptibility to infection by common bacterial pathogens. Participation of mucosal type I interferon signaling in pulmonary host defenses RELEVANCE: This project will establish the how common mucosal pathogens, S. pneumoniae, S. aureus and P. aeruginosa activate type I interferon signaling in the respiratory tract. These interferons are critical for effective anti-viral defenses but appear to increase susceptibility to bacterial infection. Activation of this cascade may be an important factor contributing to post-influenza bacterial pneumonia, the major cause of mortality associated with influenza infection.
描述(申请人提供):粘膜I型干扰素信号在肺宿主防御中的参与粘膜上皮细胞提供屏障和信号功能,以启动对呼吸道细菌感染的先天免疫反应。尤其是在呼吸道,对这种最初的促炎信号的调节是至关重要的。除了激活依赖于核因子?B的致炎基因以响应病原体外,呼吸道粘膜细胞还产生I型干扰素,即干扰素α和干扰素β,从而导致Jak-Stat信号和干扰素-β级联反应的>300效应器的激活。这种级联反应最为人所知的是它在预防病毒感染方面的主要作用,但也可能在宿主防御细菌感染方面发挥重要作用。在这个项目中,我们将通过识别粘膜上皮细胞中被激活的受体和信号成分,并通过表征这些效应因子如何影响感染的易感性,来表征常见的粘膜病原体,如肺炎链球菌、金黄色葡萄球菌和铜绿假单胞菌是如何激活I型干扰素信号的。流感感染后,呼吸道中干扰素-β的表达显著增加。据推测,干扰素信号上调的局部后果是增加了对继发性细菌感染的易感性,继发性细菌感染是流感相关死亡的主要原因。这将在流感的小鼠模型中进行测试,使用具有不同能力的流感突变株来刺激干扰素的产生,并比较它们如何影响细菌重叠感染的易感性。我们预测,粘膜上皮细胞产生的干扰素可能通过激活肺树突状细胞的作用,增加宿主对常见细菌病原体感染的易感性。黏膜I型干扰素信号参与肺宿主防御 相关性:该项目将确定常见的粘膜病原体肺炎链球菌、金黄色葡萄球菌和铜绿假单胞菌如何激活呼吸道中的I型干扰素信号。这些干扰素对有效的抗病毒防御至关重要,但似乎会增加对细菌感染的易感性。这种级联反应的激活可能是导致流感后细菌性肺炎的一个重要因素,而细菌性肺炎是与流感感染相关的死亡的主要原因。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Type I interferon response to extracellular bacteria in the airway epithelium.
I型干扰素对气道上皮细胞外细菌的反应。
  • DOI:
    10.1016/j.it.2011.09.003
  • 发表时间:
    2011-12
  • 期刊:
  • 影响因子:
    16.8
  • 作者:
    Parker D;Prince A
  • 通讯作者:
    Prince A
Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alice S Prince其他文献

Rapid Induction of Signal Transduction in Respiratory Epithelial Cells in Response to Pseudomonas aeruginosa Ligands ♦ 898
  • DOI:
    10.1203/00006450-199804001-00919
  • 发表时间:
    1998-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Adam J Ratner;Ruth A Bryan;Shari E Gelber;Mark Heath;Marion Davis;Alice S Prince
  • 通讯作者:
    Alice S Prince

Alice S Prince的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alice S Prince', 18)}}的其他基金

Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
适应宿主的肺部病原体的先天免疫清除
  • 批准号:
    10534732
  • 财政年份:
    2017
  • 资助金额:
    $ 19.92万
  • 项目类别:
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
适应宿主的肺部病原体的先天免疫清除
  • 批准号:
    10062515
  • 财政年份:
    2017
  • 资助金额:
    $ 19.92万
  • 项目类别:
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
适应宿主的肺部病原体的先天免疫清除
  • 批准号:
    10317092
  • 财政年份:
    2017
  • 资助金额:
    $ 19.92万
  • 项目类别:
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
适应宿主的肺部病原体的先天免疫清除
  • 批准号:
    10532116
  • 财政年份:
    2017
  • 资助金额:
    $ 19.92万
  • 项目类别:
MRSA Activation of Human Keratinocyte Signaling
MRSA 激活人类角质形成细胞信号传导
  • 批准号:
    8513046
  • 财政年份:
    2013
  • 资助金额:
    $ 19.92万
  • 项目类别:
Staphylococcus aureus exploitation of autophagy promotes latent infection
金黄色葡萄球菌利用自噬促进潜伏感染
  • 批准号:
    8511238
  • 财政年份:
    2013
  • 资助金额:
    $ 19.92万
  • 项目类别:
MRSA Activation of Human Keratinocyte Signaling
MRSA 激活人类角质形成细胞信号传导
  • 批准号:
    8660623
  • 财政年份:
    2013
  • 资助金额:
    $ 19.92万
  • 项目类别:
Staphylococcus aureus exploitation of autophagy promotes latent infection
金黄色葡萄球菌利用自噬促进潜伏感染
  • 批准号:
    8625699
  • 财政年份:
    2013
  • 资助金额:
    $ 19.92万
  • 项目类别:
2012 Biology of Acute Respiratory Infection Gordon Research Conference
2012年急性呼吸道感染生物学戈登研究会议
  • 批准号:
    8249190
  • 财政年份:
    2012
  • 资助金额:
    $ 19.92万
  • 项目类别:
Participation of Mucosal Type I Interferon Signaling in Pulmonary Disease
粘膜 I 型干扰素信号转导参与肺部疾病
  • 批准号:
    7706229
  • 财政年份:
    2009
  • 资助金额:
    $ 19.92万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 19.92万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 19.92万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 19.92万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 19.92万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 19.92万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 19.92万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 19.92万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 19.92万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 19.92万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 19.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了